164 related articles for article (PubMed ID: 37989907)
1. Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.
Kawaguchi T; Okamoto K; Fujimoto S; Bando M; Wada H; Miyamoto H; Sato Y; Muguruma N; Horimoto K; Takayama T
J Gastroenterol; 2024 Jan; 59(1):11-23. PubMed ID: 37989907
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map.
Wada H; Sato Y; Fujimoto S; Okamoto K; Bando M; Kawaguchi T; Miyamoto H; Muguruma N; Horimoto K; Matsuzawa Y; Mutoh M; Takayama T
Cancer Sci; 2022 Dec; 113(12):4374-4384. PubMed ID: 36082704
[TBL] [Abstract][Full Text] [Related]
3. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
[TBL] [Abstract][Full Text] [Related]
4. 5'tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer.
Wang XY; Zhou YJ; Chen HY; Chen JN; Chen SS; Chen HM; Li XB
World J Gastrointest Oncol; 2023 Jun; 15(6):1005-1018. PubMed ID: 37389118
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic diagnosis for colorectal sessile serrated lesions.
Nishizawa T; Yoshida S; Toyoshima A; Yamada T; Sakaguchi Y; Irako T; Ebinuma H; Kanai T; Koike K; Toyoshima O
World J Gastroenterol; 2021 Apr; 27(13):1321-1329. PubMed ID: 33833485
[TBL] [Abstract][Full Text] [Related]
6. Disparate age and sex distribution of sessile serrated lesions and conventional adenomas in an outpatient colonoscopy population-implications for colorectal cancer screening?
Lall V; Ismail AGM; Ayonrinde OT
Int J Colorectal Dis; 2022 Jul; 37(7):1569-1579. PubMed ID: 35660947
[TBL] [Abstract][Full Text] [Related]
7. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma.
Murakami T; Sakamoto N; Fukushima H; Shibuya T; Yao T; Nagahara A
Surg Endosc; 2021 Aug; 35(8):4528-4538. PubMed ID: 32909209
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
[TBL] [Abstract][Full Text] [Related]
11. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of EGFR and COX pathway inhibition in human colon organoids of serrated polyposis and other hereditary cancer syndromes.
Kanth P; Hazel MW; Schell JC; Rutter J; Yao R; Mills AP; Delker DA
Fam Cancer; 2024 Apr; ():. PubMed ID: 38609520
[TBL] [Abstract][Full Text] [Related]
13. Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions.
Ohki D; Tsuji Y; Hisada H; Nakagawa H; Mizutani S; Oshio K; Sato J; Kubota D; Cho R; Miura Y; Mizutani H; Sakaguchi Y; Takahashi Y; Yakabi S; Kakushima N; Yamamichi N; Ushiku T; Fujishiro M
Endosc Int Open; 2024 Mar; 12(3):E448-E455. PubMed ID: 38550765
[No Abstract] [Full Text] [Related]
14. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
[TBL] [Abstract][Full Text] [Related]
15. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of mRNA expression identified the involvement of trefoil factor 1 in the development of sessile serrated lesions.
Sugai T; Osakabe M; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Matsumoto T; Suzuki H
Pathol Res Pract; 2022 Aug; 236():153987. PubMed ID: 35749918
[TBL] [Abstract][Full Text] [Related]
17. Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?
Utsumi T; Yamada Y; Diaz-Meco MT; Moscat J; Nakanishi Y
J Gastroenterol; 2023 Aug; 58(8):705-717. PubMed ID: 37219625
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of analyzing endoscopic features in identifying the colorectal serrated sessile lesions with and without dysplasia.
Wang RG; Ren YT; Jiang X; Wei L; Zhang XF; Liu H; Jiang B
World J Clin Cases; 2023 Oct; 11(29):6995-7003. PubMed ID: 37946753
[TBL] [Abstract][Full Text] [Related]
19. Sessile serrated lesion and its borderline variant - Variables with impact on recorded data.
Mohammadi M; Garbyal RS; Kristensen MH; Madsen PM; Nielsen HJ; Holck S
Pathol Res Pract; 2011 Jul; 207(7):410-6. PubMed ID: 21680107
[TBL] [Abstract][Full Text] [Related]
20. Reappraisal of hMLH1 promoter methylation and protein expression status in the serrated neoplasia pathway.
Lee EJ; Chun SM; Kim MJ; Jang SJ; Kim do S; Lee DH; Youk EG
Histopathology; 2016 Aug; 69(2):198-210. PubMed ID: 26713412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
